Hepatic Steatosis and Fibrosis in Rheumatoid Arthritis Patients

Sohag University

Status: Not yet enrolling

Conditions: Hepatic Steatosis and Fibrosis in Rheumatoid Arthritis Patients

Treatments: Diagnostic Test: ultrasonography

Study type: Observational

Funder types: Other

Identifiers

NCT05679648

Soh-Med-22-11-17

Details and patient eligibility

About

studying the prevalence of hepatic steatosis and fibrosis in a large scale of patients with RA and healthy controls

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

1. RA according to the American College of Rheumatology (ACR)/EULAR 2010 criteria (Aletaha et al., 2010)
2. Age≥18 years

Exclusion criteria

• History of hepatitis B and C virus infection.
• Receiving hepatotoxic drugs other than RA-specific drugs.
• Alcohol abuse (i30 g/day in men and ⩾20 g/day in women).
• Diagnosis of Wilson's disease, α1-antitrypsin deficiency or hemochromatosis.
• Autoimmune liver disease.
• Cancer.
• Pregnancy.

Trial design

100 participants in 2 patient groups

Rheumatoid arthritis patients

Treatment:

Diagnostic Test: ultrasonography

control

Treatment:

Diagnostic Test: ultrasonography